Zealthy Review: GLP-1 Claims and Care

Average weight loss requires context

The FAQ discusses a broad weight-loss range across several medicines. A number spanning different drugs and treatment plans is not a precise prediction. The FDA evidence for Wegovy injection concerns a defined product, population and study duration. It does not establish an identical average for every compounded preparation or every Zealthy member. ¹²

Ask whether an expected result is drawn from a manufacturer’s trial, an internal patient dataset or a testimonial. If it comes from the service’s own experience, the follow-up period and handling of people who stopped treatment matter. A result among selected completers can answer a different question from the probability of benefit when first enrolling.

This is not an argument that weight-management medication lacks evidence. It is a request to use the right evidence. The semaglutide and tirzepatide comparison shows why trial populations and regimens should travel with a result rather than disappear behind a single headline.

The FDA letter addressed a specific marketing problem

FDA’s September 9, 2025 letter to FitRX, LLC doing business as Zealthy addressed compounded semaglutide claims that implied equivalence with approved drugs. It was a marketing and labeling finding, not a conclusion that every current prescription is contaminated or that no patient can benefit. This review does not claim a current close-out status. ³

The practical implication is to preserve the distinction between a branded finished medicine and a compounded preparation. FDA explains that compounded drugs are not approved or reviewed before marketing for safety, effectiveness and quality in the same way. If compounding is proposed, ask the prescriber what individual need it addresses and obtain the pharmacy’s identity. ⁵

Membership and bundles need different totals

The current FAQ advertises a $39 first membership month and says medicine is separate, with a compounded semaglutide starting amount tied to a three-month supply. Its policy separately explains that named doctor-plus-medication plans can bundle membership and pharmacy fulfillment. A price from one structure should not be added to or substituted into the other without confirmation. ¹⁴

Request one written quote that names the plan, treatment, term and amount due now. Ask whether a longer medication supply also requires a longer membership commitment. Confirm subsequent renewal charges and what happens when the clinician changes treatment. Those details make the comparison meaningful even before considering which service has the smallest advertised number.

Canceling renewal is not a refund for completed care

The public policy says prescription products are final once issued and filled, and identifies consultation and membership charges as nonrefundable. It describes account-based cancellation before renewal and generally no prorated refund of the current period, subject to stated exceptions or law. These are published terms, not an individualized legal determination. ⁴

A patient should know the difference between stopping future billing, canceling an unfulfilled order and ending medical treatment. Coordinate the clinical plan with the prescriber while addressing billing separately. Retain the accepted terms and confirmation of any cancellation.

Zealthy is worth comparing where its combination of care coordination and treatment choices fits a real need. Its offer is easier to assess once the plan type and exact product are fixed. Neither an insurance estimate nor a generalized expected result should substitute for those two answers.